Know Cancer

or
forgot password
  • cancer clinical trials in nevada

  • S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    University Medical Center of Southern Nevada

    Trial Locations
    University Medical Center of Southern Nevada
    Nevada Cancer Institute
    Lung Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Women's Cancer Center - La Canada

    Trial Locations
    Women's Cancer Center - La Canada
    Renown Institute for Cancer at Renown Regional Medical Center
    Ovarian Cancer, Sarcoma
    Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
    GSK Investigational Site
    Henderson, Nevada 89014
    Cancer
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    CCOP - Nevada Cancer Research Foundation

    Trial Locations
    CCOP - Nevada Cancer Research Foundation
    University Medical Center of Southern Nevada
    Melanoma (Skin)
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Center of Hope at Renown Medical Center
    Reno, Nevada 89502
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    CCOP - Nevada Cancer Research Foundation

    Trial Locations
    CCOP - Nevada Cancer Research Foundation
    University Medical Center of Southern Nevada
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin
    Women's Cancer Center of Nevada
    Las Vegas, Nevada 89109
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
    CCOP - Nevada Cancer Research Foundation
    Las Vegas, Nevada 89109-2306
    Lymphoma, Lymphoproliferative Disorder
    Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
    CCOP - Nevada Cancer Research Foundation

    Trial Locations
    CCOP - Nevada Cancer Research Foundation
    University Medical Center of Southern Nevada
    Leukemia
    Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
    Nevada Cancer Institute Dept. of Nevada Cancer (3)

    Trial Locations
    Nevada Cancer Institute Dept. of Nevada Cancer (3)
    Comprehensive Cancer Centers of Nevada CCC of Nevada Henderson (4)
    HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Saint Mary's Regional Medical Center

    Trial Locations
    Saint Mary's Regional Medical Center
    Radiation Oncology Associates - Reno
    Renown Institute for Cancer at Renown Regional Medical Center
    Colorectal Cancer, Precancerous Condition
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    Center of Hope at Renown Medical Center
    Reno, Nevada 89502
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
    Nevada Cancer Research Foundation CCOP

    Trial Locations
    Nevada Cancer Research Foundation CCOP
    Renown Regional Medical Center
    Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer, Stage II Pancreatic Cancer
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Nevada Cancer Research Foundation CCOP

    Trial Locations
    Nevada Cancer Research Foundation CCOP
    Saint Mary's Regional Medical Center
    Renown Regional Medical Center
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
    Renown Institute for Cancer at Renown Regional Medical Center
    Reno, Nevada 89502
    Brain and Central Nervous System Tumors
    A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
    Nevada Cancer Institute NVCC - Huntsman
    Las Vegas, Nevada 89135
    Melanoma
    A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
    Nevada Cancer Institute
    Las Vegas, Nevada 89135
    Non Small Cell Lung Cancer
    A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer
    Location #2
    Henderson, Nevada 89074
    Metastatic Breast Cancer
    Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
    GSK Investigational Site
    Henderson, Nevada 89014
    Leukaemia, Lymphocytic, Chronic
    Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
    Renown Institute for Cancer at Renown Regional Medical Center
    Reno, Nevada 89502
    Lung Cancer
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    Nevada Cancer Research Foundation CCOP
    Las Vegas, Nevada 89106
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
    Nevada Cancer Institute
    Las Vegas, Nevada 89135
    Prostate Cancer
    Survey of Inhibitors in Plasma-Product Exposed Toddlers
    Hemophilia Treatment Center of Las Vegas
    Las Vegas, Nevada 89109
    Hemophilia A
    PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
    Comprehensive Cancer Centers of Nevada
    Las Vegas, Nevada 89109
    Breast Cancer
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Comprehensive Cancer Care Centers of Nevada
    Henderson, Nevada 89074
    Metastatic Breast Cancer
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Women's Cancer Center - La Canada
    Las Vegas, Nevada 89169
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Connectâ„¢ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    Southern Nevada Cancer Research Foundation

    Trial Locations
    Southern Nevada Cancer Research Foundation
    VA Sierra Nevada Healthcare System
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    VA Sierra Nevada Healthcare System
    Reno, Nevada 89502
    Multiple Myeloma
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Women's Cancer Center of Nevada
    Las Vegas, Nevada 89109
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
    CCOP - Nevada Cancer Research Foundation

    Trial Locations
    CCOP - Nevada Cancer Research Foundation
    University Medical Center of Southern Nevada
    Malignant Mesothelioma